Cargando…

Association among chronic kidney disease, airflow limitation, and mortality in a community-based population: The Yamagata (Takahata) study

Chronic kidney disease (CKD) and chronic obstructive pulmonary disease (COPD) are known risk factors for mortality. In this study, we examined the overlap of CKD and airflow limitation (AFL) that characterises COPD and its effect on 10-year mortality in a community-based population. This study inclu...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Natsuko, Matsuki, Eri, Araumi, Akira, Ashitomi, Sakiko, Watanabe, Sayumi, Kudo, Kosuke, Ichikawa, Kazunobu, Inoue, Sumito, Watanabe, Masafumi, Ueno, Yoshiyuki, Ishizawa, Kenichi, Kayama, Takamasa, Konta, Tsuneo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101320/
https://www.ncbi.nlm.nih.gov/pubmed/32221372
http://dx.doi.org/10.1038/s41598-020-62540-8
_version_ 1783511591923220480
author Suzuki, Natsuko
Matsuki, Eri
Araumi, Akira
Ashitomi, Sakiko
Watanabe, Sayumi
Kudo, Kosuke
Ichikawa, Kazunobu
Inoue, Sumito
Watanabe, Masafumi
Ueno, Yoshiyuki
Ishizawa, Kenichi
Kayama, Takamasa
Konta, Tsuneo
author_facet Suzuki, Natsuko
Matsuki, Eri
Araumi, Akira
Ashitomi, Sakiko
Watanabe, Sayumi
Kudo, Kosuke
Ichikawa, Kazunobu
Inoue, Sumito
Watanabe, Masafumi
Ueno, Yoshiyuki
Ishizawa, Kenichi
Kayama, Takamasa
Konta, Tsuneo
author_sort Suzuki, Natsuko
collection PubMed
description Chronic kidney disease (CKD) and chronic obstructive pulmonary disease (COPD) are known risk factors for mortality. In this study, we examined the overlap of CKD and airflow limitation (AFL) that characterises COPD and its effect on 10-year mortality in a community-based population. This study included 1,233 health check-up participants (mean age, 63.7 years; 46.7% men). We defined serum creatinine-based CKD (CKDcr) and serum cystatin C-based CKD (CKDcys) as glomerular filtration rate <60 mL/min/1.73 m(2), estimated using serum creatinine or cystatin C, and/or dipstick proteinuria ≥1+. AFL was defined as forced expiratory volume in 1 s to forced vital capacity ratio <70% on spirometry. Compared with subjects without AFL, those with AFL showed a significantly higher prevalence of CKDcys but not of CKDcr. Cox proportional hazard analysis adjusted for confounders showed that the hazard ratio (95% confidence interval) for all-cause mortality was 1.45 (0.77–2.63) in subjects with CKDcys alone, 1.29 (0.60–2.54) in those with AFL alone, and 2.94 (1.33–6.12) in those with both CKDcys and AFL, with subjects without both AFL and CKD as the reference. This study showed that AFL and CKDcys are strongly associated and that their overlap is a significant risk factor for mortality in community-based populations.
format Online
Article
Text
id pubmed-7101320
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-71013202020-03-31 Association among chronic kidney disease, airflow limitation, and mortality in a community-based population: The Yamagata (Takahata) study Suzuki, Natsuko Matsuki, Eri Araumi, Akira Ashitomi, Sakiko Watanabe, Sayumi Kudo, Kosuke Ichikawa, Kazunobu Inoue, Sumito Watanabe, Masafumi Ueno, Yoshiyuki Ishizawa, Kenichi Kayama, Takamasa Konta, Tsuneo Sci Rep Article Chronic kidney disease (CKD) and chronic obstructive pulmonary disease (COPD) are known risk factors for mortality. In this study, we examined the overlap of CKD and airflow limitation (AFL) that characterises COPD and its effect on 10-year mortality in a community-based population. This study included 1,233 health check-up participants (mean age, 63.7 years; 46.7% men). We defined serum creatinine-based CKD (CKDcr) and serum cystatin C-based CKD (CKDcys) as glomerular filtration rate <60 mL/min/1.73 m(2), estimated using serum creatinine or cystatin C, and/or dipstick proteinuria ≥1+. AFL was defined as forced expiratory volume in 1 s to forced vital capacity ratio <70% on spirometry. Compared with subjects without AFL, those with AFL showed a significantly higher prevalence of CKDcys but not of CKDcr. Cox proportional hazard analysis adjusted for confounders showed that the hazard ratio (95% confidence interval) for all-cause mortality was 1.45 (0.77–2.63) in subjects with CKDcys alone, 1.29 (0.60–2.54) in those with AFL alone, and 2.94 (1.33–6.12) in those with both CKDcys and AFL, with subjects without both AFL and CKD as the reference. This study showed that AFL and CKDcys are strongly associated and that their overlap is a significant risk factor for mortality in community-based populations. Nature Publishing Group UK 2020-03-27 /pmc/articles/PMC7101320/ /pubmed/32221372 http://dx.doi.org/10.1038/s41598-020-62540-8 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Suzuki, Natsuko
Matsuki, Eri
Araumi, Akira
Ashitomi, Sakiko
Watanabe, Sayumi
Kudo, Kosuke
Ichikawa, Kazunobu
Inoue, Sumito
Watanabe, Masafumi
Ueno, Yoshiyuki
Ishizawa, Kenichi
Kayama, Takamasa
Konta, Tsuneo
Association among chronic kidney disease, airflow limitation, and mortality in a community-based population: The Yamagata (Takahata) study
title Association among chronic kidney disease, airflow limitation, and mortality in a community-based population: The Yamagata (Takahata) study
title_full Association among chronic kidney disease, airflow limitation, and mortality in a community-based population: The Yamagata (Takahata) study
title_fullStr Association among chronic kidney disease, airflow limitation, and mortality in a community-based population: The Yamagata (Takahata) study
title_full_unstemmed Association among chronic kidney disease, airflow limitation, and mortality in a community-based population: The Yamagata (Takahata) study
title_short Association among chronic kidney disease, airflow limitation, and mortality in a community-based population: The Yamagata (Takahata) study
title_sort association among chronic kidney disease, airflow limitation, and mortality in a community-based population: the yamagata (takahata) study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101320/
https://www.ncbi.nlm.nih.gov/pubmed/32221372
http://dx.doi.org/10.1038/s41598-020-62540-8
work_keys_str_mv AT suzukinatsuko associationamongchronickidneydiseaseairflowlimitationandmortalityinacommunitybasedpopulationtheyamagatatakahatastudy
AT matsukieri associationamongchronickidneydiseaseairflowlimitationandmortalityinacommunitybasedpopulationtheyamagatatakahatastudy
AT araumiakira associationamongchronickidneydiseaseairflowlimitationandmortalityinacommunitybasedpopulationtheyamagatatakahatastudy
AT ashitomisakiko associationamongchronickidneydiseaseairflowlimitationandmortalityinacommunitybasedpopulationtheyamagatatakahatastudy
AT watanabesayumi associationamongchronickidneydiseaseairflowlimitationandmortalityinacommunitybasedpopulationtheyamagatatakahatastudy
AT kudokosuke associationamongchronickidneydiseaseairflowlimitationandmortalityinacommunitybasedpopulationtheyamagatatakahatastudy
AT ichikawakazunobu associationamongchronickidneydiseaseairflowlimitationandmortalityinacommunitybasedpopulationtheyamagatatakahatastudy
AT inouesumito associationamongchronickidneydiseaseairflowlimitationandmortalityinacommunitybasedpopulationtheyamagatatakahatastudy
AT watanabemasafumi associationamongchronickidneydiseaseairflowlimitationandmortalityinacommunitybasedpopulationtheyamagatatakahatastudy
AT uenoyoshiyuki associationamongchronickidneydiseaseairflowlimitationandmortalityinacommunitybasedpopulationtheyamagatatakahatastudy
AT ishizawakenichi associationamongchronickidneydiseaseairflowlimitationandmortalityinacommunitybasedpopulationtheyamagatatakahatastudy
AT kayamatakamasa associationamongchronickidneydiseaseairflowlimitationandmortalityinacommunitybasedpopulationtheyamagatatakahatastudy
AT kontatsuneo associationamongchronickidneydiseaseairflowlimitationandmortalityinacommunitybasedpopulationtheyamagatatakahatastudy